Hormone receptor positive HER2 negative breast cancer

• A Phase 3 Study of DB-1303 vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer Recruitment ended
  2023-507333-17-00 5 2024-04-15 "HER2-low, Hormone Receptor Positive, Metastatic Breast Cance"
• A phase Ib dose finding study assessing safety and activity of [177Lu]Lu-NeoB in combination with ribociclib and fulvestrant in participants … Recruitment ended
  2022-502465-18-00 9 2024-02-15 "Advanced or metastatic breast cancer"
• A Study to Evaluate the Efficacy and Safety of Giredestrant Plus Everolimus Compared with the Physician’s Choice of Endocrine Therapy Plus E … Recruitment ended
  2023-506821-12-00 5 2023-10-12 "Estrogen Receptor (ER)-Positive, HER2-Negative, Locally Adva"
• Phase 3 Clinical Trial of Gedatolisib in Patients with HR Positive, HER2 Negative Advanced or Metastatic Breast Cancer (VIKTORIA-1) Recruitment ended
  2022-502145-10-00 5 2023-06-06 "Hormone Receptor (HR)-Positive, Human Epidermal Growth Facto"
• SEQUEL-Breast: a phase 2 study on the combination of alpelisib and fulvestrant after progression on previous therapy with fulvestrant in pat … Recruitment ended
  2024-514965-20-00 4 2022-06-02 "Breast cancer"
• Efficacy and Safety Comparison of Niraparib to Placebo in Participants with HER2 Negative BRCAmut or Triple-Negative Breast Cancer with Mole … Recruitment ended
  2023-504454-35-00 5 2021-06-22 "Neoplasms, Breast"
• Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk … Recruitment ended
  2024-515769-32-00 5 2019-07-02 "HR+/HER2- early breast cancer"
• Phase III study of pembrolizumab for high-risk early-stage ER+/HER2– breast cancer Recruitment ended
  2023-506921-12-00 5 2018-12-27 "ER+/HER2- Breast Cancer"
• Endocrine therapy plus CDK 4/6 inhibition in first- or second-line for hormone receptor positive advanced breast cancer - the SONIA study Recruitment ended
  2024-516204-42-00 5 2017-11-21 "Breast cancer"
• A Study to Learn If The Study Medicine Called Fluconazole Changes How the Body Processes The Other Study Medicine PF-07248144 Ended
  2025-521924-31-00 3 2025-08-20 "locally advanced or metastatic HR+/HER2- breast cancer"
• A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-A3 … Ended
  2023-505322-34-00 1 2024-01-08 "Advanced or metastatic solid tumors"
• A Study of SGN-B7H4V in Advanced Solid Tumors Ended
  2023-503389-22-00 1 2022-08-31 "Fallopian tube cancer"
• A randomized, 2-arm, open-label, phase II study of abemaciclib combined with endocrine therapy (letrozole or fulvestrant) with or without a … Ended
  2023-509591-42-00 4 2021-05-04 "HR-positive/HER2-negative breast cancer"

Showing 25–37 of 37 trials